THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
*FY 2020 Appropriationsn; provisions related to development, acquisition, and stockpilling of medical countermeasures for the U.S.Government. *Re-authorization of the Pandemic and All-Hazards Preperedness Act. *NDAA-provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Homeland Security HOM
FY 2020 Appropriations;provisions related to development, acquisition, and stockpilling of medical countermeasures for the U.S. Government.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Defense DEF
*FY 2020 Appropriations:provisions related to development, acquisition, and stockpilling of medical countermeasures fo the U.S. Government. *Re-Authorization of the Pandemic and All-Hazards Preparedness Act. *NDAA:provisions related to biological and chemical defense. *Department of Defense appropriations foe Medical Countermeasures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Disaster Planning/Emergencies DIS
* FY 2020 Approppriations; provisions related to development,acquisition, and stockpilling of medical countermeasures for the U.S. Government. * Re-authorization of the Pandemic and All-Hazards Preparedness Act. *NDAA;Provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Health Issues HCR
*FDA regulatory issues. *Issues related to Priority Review Voucher programs. *Opioid and heroin addiction Legislation, Naloxone access, coprescribing/opioid prescribing guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.